Europe’s BAPS Swaminarayan Sanstha is supporting their community during the coronavirus pandemic by spreading awareness of the PRINCIPLE trial of Covid-19 treatments. Led by Oxford University researchers, the PRINCIPLE trial is working across all UK communities to evaluate if treatment administered early in the course of the Covid-19 illness can help people aged over 50 […]
Initial findings from a study looking at the longer-term impact of COVID-19 has found that a large proportion COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus. The University of Oxford scientists carrying out the C-MORE study have also detected abnormalities […]
Oxford University Hospitals NHS Foundation Trust and IMPOWER Consulting have announced a collaborative working agreement in relation to improving impact to health and social care. The aim of the partnership is two-fold. Using its advanced capabilities in technology and digital, the Trust will work with IMPOWER to drive innovation that will benefit health and social […]
“Ten years of concerted, catalytic and collaborative action to improve the lives of older people, their families, and the communities in which they live”. World Health Organisation Oxford Brookes University is delighted to mark the Decade of Healthy Ageing with a month of free lunchtime seminars, workshops and talks to illustrate the breadth and depth […]
A team of mathematical modellers and epidemiologists at Oxford University’s Nuffield Department of Medicine release the latest model of a population responding to the coronavirus epidemic. The model – OpenABM-Covid19 – provides public health decision-makers with the ability to review the potential progression and outcome of the coronavirus, including fluctuations in infected individuals, hospitalisations, intensive care unit […]
Oxford Brookes spinout company Oxford Expression Technologies has been awarded a grant from Innovate UK to support a partnership with Vaxine Pty Ltd to develop a vaccine for COVID-19. The grant will accelerate the creation of the Covax-19® vaccine, which is being developed by Vaxine, an Australian biotechnology company focussing on the development of innovative […]
The International Severe Acute Respiratory and emerging Infection Consortium (ISARIC), based at Oxford University, in collaboration with Dr Janet Scott, of the MRC-University of Glasgow’s Centre for Virus Research, has launched a longitudinal observational study to measure prevalence and risk factors of long-term health and psycho-social consequences of COVID-19. The researchers are inviting hospitals and […]
A study involving Oxford researchers has found that having had a liver transplant does not increase the risk of death from COVID-19, but that other factors such as age and comorbidities among liver transplant recipients do. The researchers from the Oxford Liver Unit, based at Oxford University Hospitals (OUH) NHS Foundation Trust, and the University of […]
A new arm of the ongoing global clinical trials of the ChAdOx1 nCoV-19 vaccine led by AstraZeneca has launched in the US to assess safety, efficacy and immunogenicity of the vaccine for the prevention of COVID-19. Our vaccine work is progressing quickly. To ensure you have the latest information or to find out more about […]
With support from Royal Philips, Oxford University Hospitals (OUH) NHS Foundation Trust has become one of the earliest UK adopters of a fully digitised cellular pathology (histopathology) department. OUH is one of the first NHS trusts in the country to achieve the milestone of digitising all surgical histology and referral slides within the cellular pathology department. This […]